Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an ...

Prostate cancer has become the most commonly diagnosed cancer in England, with Sky News' Dermot Murnaghan sharing his stage ...

The public health system in England offered me palliative care. It was a death sentence I wasn't willing to accept. I wasn't ready to leave behind my six children: Matt, 35; Will, 24; Hannah, 19; ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

Approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the injectable will cut down on immunotherapy ...

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...

A mum who has breast cancer is one of thousands of women who could be "missing out" on life-extending drugs because of the way they are assessed by the health service, a charity has warned. Breast ...

A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy ...

The Personalised Breast Cancer Programme (PBCP) is now available at James Paget University Hospital in Gorleston. The PBCP uses whole genome sequencing to analyse tumour DNA and identify genetic ...

Scientists at the University of Cambridge have created a test that could predict if a cancer patient is sensitive or resistant to different types of chemotherapy. This could help thousands of patients ...

According to Dr Raj, ‘a self-test means that the patient has more control over any potential discomfort and also the test ...